The Valence Group Advises Niacet on Its Sale to SK Capital
The Valence Group has advised Niacet Corporation on its sale to SK Capital Partners. Financial terms of the transaction were not disclosed.
SK Capital is recapitalizing Niacet in partnership with Kelly Brannen, who will continue to serve as CEO and retain a significant stake in the Company. The transaction follows nearly four decades of Brannen family ownership after the purchase of Niacet from Union Carbide in 1978, during which time the Company grew significantly to become the worldwide leader in its core products.
About Niacet Corporation
Niacet is a leading producer of organic salts, including propionates and acetates, serving the food, feed, pharmaceutical and technical industries. With two fully automated manufacturing sites, located in Niagara Falls, NY and Tiel, The Netherlands, Niacet offers world-class quality products to global markets that fill vital needs in a broad range of applications that are essential to everyday life including food preservation, antibiotic formulation, dialysis treatment and energy production.
About The Valence Group
The Valence Group is a specialist investment bank offering M&A advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The Valence Group team includes a unique combination of professionals with backgrounds in investment banking and strategy consulting within the chemicals and materials industries, all focused exclusively on providing M&A advisory services to the chemicals and materials sector. The firm’s offices are located in New York and London.
The Valence Group
Paul Lakind, 212-847-7339
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
ASTRAZENECA17.10.2017 00:02 | pressemeddelelse
AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activity in 2nd-Line EGFR Mutation-positive Lung Cancer with MET-amplification
FL-MLB16.10.2017 23:36 | pressemeddelelse
Orlando Melbourne Int’l (MLB) Lands Largest FAA Grant in Its History
IDEMIA16.10.2017 16:36 | pressemeddelelse
Colombia Selects IDEMIA to Upgrade Its Identification and Civil Registry Platform
NY-MUREX16.10.2017 16:02 | pressemeddelelse
ATB Financial Goes-Live on Murex’s SaaS Solution
PRINT24.COM16.10.2017 16:01 | pressemeddelelse
Leave a review on print24.com and win a VW up!
BENTLEY-SYSTEMS16.10.2017 15:54 | pressemeddelelse
Bentley Systems Announces Winners of 2017 Be Inspired Awards
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum